Kessler Topaz Meltzer & Check, LLP - GeneDx Holdings Corp. (WGS) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit

A securities fraud class action lawsuit has been filed against GeneDx Holdings Corp. (NASDAQ: WGS) for allegedly making material misstatements about the viability of its $51 million acquisition of Fabric Genomics. The company wrote off a $31.3 million impairment loss on the Fabric acquisition in Q1 2026, causing WGS stock to plummet over 49%. Investors who purchased WGS stock between April 16, 2025, and May 4, 2026, can seek lead plaintiff status by August 3, 2026.